Neola Medical AB(SE:NEOLA)
kr 0.48+0.01 (+2.13%)
SE:NEOLA
Neola Medical AB financials statements
kr 0.48
At close:+0.01 (+2.13%)
Want to see SE:NEOLA full AI Analyst Report?
Neola Medical AB (NEOLA) Ratios
0 Followers
Neola Medical AB Ratios
SE:NEOLA's free cash flow for Q4 2025 was kr-3.77M. For the 2025 fiscal year, SE:NEOLA's free cash flow was increased by kr2.83M and operating cash flow was kr-2.83M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 5.75 | 4.53 | 7.00 | 7.78 | 7.76 |
| Quick Ratio | 5.75 | 4.51 | 7.00 | 7.78 | 7.76 |
| Cash Ratio | 5.38 | 4.21 | 3.50 | 7.50 | 7.18 |
| Solvency Ratio | -3.21 | -1.84 | -1.08 | -1.25 | -2.08 |
| Operating Cash Flow Ratio | -3.99 | -2.33 | -1.06 | -1.59 | -2.17 |
| Short-Term Operating Cash Flow Coverage | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Current Asset Value | kr 14.24M | kr 16.39M | kr 36.12M | kr 33.76M | kr 21.59M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debt-to-Equity Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.04 | 1.07 | 1.09 | 1.12 | 1.08 |
| Debt Service Coverage Ratio | -51.60 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Coverage Ratio | -58.93 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debt to Market Cap | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Debt to EBITDA | 1.65 | 2.29 | 2.85 | 4.08 | 3.46 |
| Profitability Margins | |||||
| Gross Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | -1176.96% |
| EBIT Margin | 0.00% | 0.00% | 0.00% | 0.00% | -1064.48% |
| EBITDA Margin | 0.00% | 0.00% | 0.00% | 0.00% | -1062.08% |
| Operating Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | -1176.96% |
| Pretax Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | -1064.48% |
| Net Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | -1064.48% |
| Continuous Operations Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | -1064.48% |
| Net Income Per EBT | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
| EBT Per EBIT | 98.96% | 90.98% | 93.65% | 99.61% | 90.44% |
| Return on Assets (ROA) | -13.99% | -13.67% | -10.47% | -13.74% | -15.18% |
| Return on Equity (ROE) | -14.54% | -14.59% | -11.40% | -15.34% | -16.37% |
| Return on Capital Employed (ROCE) | -14.69% | -16.04% | -12.05% | -14.85% | -18.10% |
| Return on Invested Capital (ROIC) | -14.69% | -16.04% | -12.05% | -14.85% | -18.10% |
| Return on Tangible Assets | -62.67% | -47.37% | -20.84% | -24.75% | -26.67% |
| Earnings Yield | -13.57% | -7.10% | -7.88% | -29.42% | -14.17% |
| Efficiency Ratios | |||||
| Receivables Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.43 |
| Payables Turnover | 0.96 | 1.43 | 0.66 | 0.38 | 6.13 |
| Inventory Turnover | 0.00 | 18.40 | 0.00 | 21.15 | 0.00 |
| Fixed Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 3.86 |
| Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 |
| Working Capital Turnover Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.03 |
| Cash Conversion Cycle | -380.29 | -235.45 | -555.01 | -937.11 | 786.67 |
| Days of Sales Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 846.22 |
| Days of Inventory Outstanding | 0.00 | 19.84 | 0.00 | 17.26 | 0.00 |
| Days of Payables Outstanding | 380.29 | 255.28 | 555.01 | 954.37 | 59.55 |
| Operating Cycle | 0.00 | 19.84 | 0.00 | 17.26 | 846.22 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.16 | -0.15 | -0.12 | -0.33 | -0.38 |
| Free Cash Flow Per Share | -0.28 | -0.15 | -0.34 | -0.77 | -0.96 |
| Dividend Paid and CapEx Coverage Ratio | -1.00 | 0.00 | -0.53 | -0.74 | -0.66 |
| Capital Expenditure Coverage Ratio | -1.00 | 0.00 | -0.53 | -0.74 | -0.66 |
| Operating Cash Flow Coverage Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Cash Flow to Sales Ratio | 0.00 | 0.00 | 0.00 | 0.00 | -11.09 |
| Free Cash Flow Yield | -26.16% | -7.65% | -16.49% | -56.98% | -37.17% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -7.57 | -14.43 | -12.69 | -3.40 | -7.06 |
| Price-to-Sales (P/S) Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 75.11 |
| Price-to-Book (P/B) Ratio | 1.07 | 2.05 | 1.45 | 0.52 | 1.16 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -3.82 | -13.08 | -6.07 | -1.76 | -2.69 |
| Price-to-Operating Cash Flow Ratio | -6.80 | -13.08 | -17.47 | -4.14 | -6.77 |
| Price-to-Earnings Growth (PEG) Ratio | 0.00 | 1.15 | 0.21 | -0.42 | 0.15 |
| Enterprise Value Multiple | -6.68 | -14.31 | -12.24 | 0.50 | -3.62 |
| Enterprise Value | 65.13M | 122.15M | 92.74M | -4.89M | 24.00M |
| EV to EBITDA | -6.68 | -14.31 | -12.24 | 0.50 | -3.62 |
| EV to Sales | 0.00 | 0.00 | 0.00 | 0.00 | 38.41 |
| EV to Free Cash Flow | -3.06 | -11.27 | -4.92 | 0.24 | -1.38 |
| EV to Operating Cash Flow | -5.45 | -11.27 | -14.18 | 0.58 | -3.46 |
| Tangible Book Value Per Share | 0.19 | 0.24 | 0.65 | 1.30 | 1.20 |
| Shareholders’ Equity Per Share | 0.99 | 0.98 | 1.42 | 2.59 | 2.23 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.03 |
| Net Income Per Share | -0.14 | -0.14 | -0.16 | -0.40 | -0.37 |
| Tax Burden | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Interest Burden | 0.99 | 1.00 | 1.00 | 1.00 | 1.00 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 18.48 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 1.08 | 1.08 | 0.73 | 0.82 | 1.04 |
Currency in SEK

